Avion Wealth’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Buy
394
+138
+54% +$199 ﹤0.01% 1548
2026
Q1
$0 Buy
+256
New +$482 ﹤0.01% 1394
2025
Q4
Sell
-140
Closed 1381
2025
Q3
$0 Buy
+140
New +$479 ﹤0.01% 1341

Other funds holding HCAT

Avion Wealth's HCAT Position: Q2 2026 in Review

Avion Wealth increased its Health Catalyst (HCAT) stake by 54% in Q2 2026, buying an estimated $199 and bringing the position to 394 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Avion Wealth first reported a position in HCAT in Q3 2025 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Avion Wealth held 394 shares of Health Catalyst worth $0 as of Q2 2026.
  • Avion Wealth bought 138 Health Catalyst shares in Q2 2026, an estimated $199.
  • Health Catalyst made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1548 holding.
  • Avion Wealth first reported a position in Health Catalyst in Q3 2025 and has held it in 3 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.